Medpace Holdings, Inc. (NASDAQ:MEDP - Get Free Report) shares reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $289.03 and last traded at $293.87, with a volume of 120127 shares traded. The stock had previously closed at $312.36.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on MEDP shares. Leerink Partnrs raised shares of Medpace to a "hold" rating in a research report on Monday, March 24th. Leerink Partners initiated coverage on shares of Medpace in a report on Monday, March 24th. They set a "market perform" rating and a $330.00 price target for the company. Finally, Robert W. Baird lifted their price objective on shares of Medpace from $354.00 to $362.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. Nine investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Medpace currently has an average rating of "Hold" and an average target price of $376.30.
Get Our Latest Analysis on MEDP
Medpace Trading Down 5.6 %
The company has a market capitalization of $8.75 billion, a P/E ratio of 22.73, a PEG ratio of 3.81 and a beta of 1.45. The stock has a 50 day moving average price of $332.70 and a 200 day moving average price of $338.09.
Medpace (NASDAQ:MEDP - Get Free Report) last posted its earnings results on Monday, February 10th. The company reported $3.67 EPS for the quarter, beating the consensus estimate of $2.96 by $0.71. Medpace had a return on equity of 51.48% and a net margin of 19.17%. On average, research analysts predict that Medpace Holdings, Inc. will post 12.29 EPS for the current year.
Institutional Investors Weigh In On Medpace
A number of institutional investors have recently added to or reduced their stakes in MEDP. R Squared Ltd acquired a new position in shares of Medpace during the fourth quarter worth $30,000. SBI Securities Co. Ltd. acquired a new position in Medpace during the 4th quarter worth about $31,000. Jones Financial Companies Lllp grew its position in shares of Medpace by 2,750.0% in the 4th quarter. Jones Financial Companies Lllp now owns 114 shares of the company's stock valued at $38,000 after buying an additional 110 shares during the last quarter. Lindbrook Capital LLC increased its stake in shares of Medpace by 27.6% in the fourth quarter. Lindbrook Capital LLC now owns 134 shares of the company's stock valued at $45,000 after buying an additional 29 shares during the period. Finally, Assetmark Inc. increased its stake in shares of Medpace by 20.1% in the fourth quarter. Assetmark Inc. now owns 173 shares of the company's stock valued at $57,000 after buying an additional 29 shares during the period. 77.98% of the stock is owned by institutional investors.
About Medpace
(
Get Free Report)
Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.
Featured Stories
Before you consider Medpace, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medpace wasn't on the list.
While Medpace currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
